This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Scott Bertch
Executive Director, Clinical Manufacturing Site Head at Tenaya Therapeutics


Scott Bertch is currently Executive Director, Clinical Site Head at Tenaya Therapeutics. Scott has 25 years of experience in the pharmaceutical and biotechnology field specializing in the design, construction, automation and validation of production facilities. Scott has developed and maintained programs for engineering project delivery, equipment acquisition, and commissioning & qualification. Prior to Joining Tenaya, Scott served as Senior Director of Technical Operations at Novartis Gene Therapies where he executed major capital projects to design and construct manufacturing, laboratories, warehousing and office complexes for cutting-edge gene therapy manufacturing technologies and modular facility design. Scott’s areas of expertise include applying engineering, validation, and automated solutions to complex processes in the biotech and gene therapy space.

Agenda Sessions

  • Business Advantages of Starting Early with Gene Therapy Manufacturing + Key Considerations